Company: PED
Filing Date: 2025-07-11
Form Type: DEF 14A
Source: 0001654954-25-007979
Chunk: 38

Company: PEDEVCO CORP
Filing Date: 2025-07-11
Form: DEF 14A
Chunk 38
---
 Date”) (vested); (ii) 1/3 on the two (2) year anniversary of the Grant Date (vested); and (iii) 1/3 on the three (3) year anniversary of the Grant Date (collectively, the “Three Year Vesting Terms”), subject to Mr. Pinkston’s continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into between the Company and Mr. Pinkston; |
| (B) | 400,000 shares to Dr. Simon G. Kukes, the then Chief Executive Officer of the Company, all of which are subject to the Three Year Vesting Terms, subject to Dr. Kukes’ continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into between the Company and Dr. Kukes;                                                                                                                                                                                                                                                                                   |
| (C) | 350,000 shares to Mr. J. Douglas Schick, the President of the Company, all of which are subject to the Three Year Vesting Terms, subject to Mr. Schick’s continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into between the Company and Mr. Schick;                                                                                                                                                                                                                                                                                                |
| (D) | 300,000 shares to Mr. Clark R. Moore, the Executive Vice President, General Counsel and Secretary of the Company, all of which are subject to the Three Year Vesting Terms, subject to Mr. Moore’s continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into between the Company and Mr. Moore; and                                                                                                                                                                                                                                                   |
| (F) | five year options to purchase 540,000 shares of restricted Company common stock with an exercise price of $1.09 per share to certain other non-executive employees of the Company, all of which are subject to the Three Year Vesting Terms, subject to such recipient’s continued service to the Company on such vesting dates, and subject to the terms and conditions of a Stock Option Grant Agreement entered into between the Company and each such recipient.                                                                                                                                                                            |

On August 31, 2023, the Company granted (i) 125,000 shares of restricted Company common stock under the Company’s Plan to Mr. John Scelfo, our then Chairman, which shares vested on July 12,